The final, formatted version of the article will be published soon.
REVIEW article
Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1387292
Sterile Inflammation of Peritoneal Membrane Caused by Peritoneal Dialysis: Focus on the Communication between Immune Cells and Peritoneal Stroma
Provisionally accepted- Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Peritoneal dialysis is a widely used method for treating kidney failure. However, over time, the peritoneal structure and function can deteriorate, leading to the failure of this therapy. This deterioration is primarily caused by infectious and sterile inflammation. Aseptic peritonitis, which is inflammation without infection, is particularly concerning as it can be subtle and often goes unnoticed. The onset of sterile inflammation involves various pathological processes. Peritoneal cells detect signals that promote inflammation and release substances that attract immune cells from the bloodstream. These immune cells contribute to the initiation and escalation of the inflammatory response. The existing literature extensively covers the involvement of different cell types in the aseptic peritonitis, including mesothelial cells, fibroblasts, endothelial cells, and adipocytes, as well as immune cells such as macrophages, lymphocytes, and mast cells. These cells work together to promote the occurrence and progression of sterile inflammation, although the exact mechanisms are not fully understood. This review aims to provide a comprehensive overview of the signals from both stromal cells and components of immune system, as well as the reciprocal interactions between cellular components, during the initiation of sterile inflammation.By understanding the cellular and molecular mechanisms underlying sterile inflammation, we may potentially develop therapeutic interventions to counteract peritoneal membrane damage and restore normal function.
Keywords: peritoneal dialysis fluids, non-bioincompatible, Sterile Inflammation, immune cells, mesothelial cells 2.Introduction
Received: 17 Feb 2024; Accepted: 16 Apr 2024.
Copyright: © 2024 Su, Rong, Su, Chen, Yang, An, Yang, Tang, Liu and Yao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jin-Qi Su, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Xiao-Cui Chen, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Hai- Juan Yang, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Ji-Xin Tang, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Huafeng Liu, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Cui-Wei Yao, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.